Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region-Reference-Cited by-同舟云学术

Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region

Published:2021-05-01 Issue:5 Volume:28 Page:417-434
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Kalra Sanjay¹,Chen Zhenyue²,Deerochanawong Chaicharn³,Shyu Kou-Gi⁴,Tan Ru San⁵,Tomlinson Brian⁶,Yeh Hung-I⁷

Affiliation:

1. Department of Endocrinology, Bharti Hospital

2. Cardiology Department, Shanghai Ruijin Hospital, Shanghai Jiaotong University School of Medicine

3. Rajavithi hospital, College of Medicine, Rangsit University

4. Division of Cardiology, Shin Kong Wu Ho-Su Memorial Hospital

5. National Heart Centre Singapore, Duke-NUS Medical Singapore

6. Faculty of Medicine, Macau University of Science & Technology

7. Departments of Internal Medicine and Medical Research, Mackay Memorial Hospital, Mackay Medical College

Publisher

Japan Atherosclerosis Society

Subject

Biochemistry, medical,Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/jat/28/5/28_56762/_pdf

Reference95 articles.

1. 1) Vallejo-Vaz AJ, Kondapally Seshasai SR, Cole D, Hovingh GK, Kastelein JJ, Mata P, Raal FJ, Santos RD, Soran H, Watts GF, Abifadel M, Aguilar-Salinas CA, Akram A, Alnouri F, Alonso R, Al-Rasadi K, Banach M, Bogsrud MP, Bourbon M, Bruckert E, Car J, Corral P, Descamps O, Dieplinger H, Durst R, Freiberger T, Gaspar IM, Genest J, Harada-Shiba M, Jiang L, Kayikcioglu M, Lam CS, Latkovskis G, Laufs U, Liberopoulos E, Nilsson L, Nordestgaard BG, O’Donoghue JM, Sahebkar A, Schunkert H, Shehab A, Stoll M, Su TC, Susekov A, Widen E, Catapano AL and Ray KK: Familial hypercholesterolaemia: A global call to arms. Atherosclerosis, 2015; 243: 257-259

2. 2) Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, Wiklund O, Hegele RA, Raal FJ, Defesche JC, Wiegman A, Santos RD, Watts GF, Parhofer KG, Hovingh GK, Kovanen PT, Boileau C, Averna M, Boren J, Bruckert E, Catapano AL, Kuivenhoven JA, Pajukanta P, Ray K, Stalenhoef AF, Stroes E, Taskinen MR, Tybjaerg-Hansen A and European Atherosclerosis Society Consensus P: Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J, 2013; 34: 3478-3490a

3. 3) Bell DA and Watts GF: Progress in the care of familial hypercholesterolaemia: 2016. Med J Aust, 2016; 205: 232-236

4. 4) United Nations Department of Economic and Social Affairs Population Division: World Population Prospects: The 2017 Revision, Key Findings and Advance Tables. Working Paper No. ESA/P/WP.248. 2017;

5. 5) Watts GF, Ding PY, George P, Hagger MS, Hu M, Lin J, Khoo KL, Marais AD, Miida T, Nawawi HM, Pang J, Park JE, Gonzalez-Santos LB, Su TC, Truong TH, Santos RD, Soran H, Yamashita S, Tomlinson B and for tha members of the “Ten countries S: Translational Research for Improving the Care of Familial Hypercholesterolemia: The “Ten Countries Study” and Beyond. J Atheroscler Thromb, 2016; 23: 891-900

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening for familial hypercholesterolemia in Sri Lanka: A laboratory-based multicenter study;International Journal of Noncommunicable Diseases;2024-04

2. A case report of heterozygous familial hypercholesterolaemia with LDLR gene mutation complicated by premature coronary artery disease detected in primary care;European Heart Journal - Case Reports;2024-01-29

3. Gaps in the Care of Subjects with Familial Hypercholesterolemia: Insights from the Thai Familial Hypercholesterolemia Registry;Journal of Atherosclerosis and Thrombosis;2023-12-01

4. Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients;Progress in Cardiovascular Diseases;2023-07

5. Barriers and shortcomings in access to cardiovascular management and prevention for familial hypercholesterolemia during the COVID‐19 pandemic;Clinical Cardiology;2023-06